You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The NEO Iris instrument uses the company's Capture solid phase technology for antibody screening and identification, and can run up to 60 tests and screens per hour.
The Canadian company said it will use the funding to support the US launch of its rapid, noninvasive test for platelet activation status.
Designed for small and medium-sized labs, the system offers automated blood typing and screening based on gel card technology with minimum user intervention.
The firm said that it is now working toward obtaining the necessary regulatory classification to allow placement of its platelet testing devices in physician offices.
Magnolia has amended a complaint filed in a US District Court to allege that Kurin infringes four Magnolia patents.
The company's full-year revenues rose 6 percent and were slightly higher than the consensus Wall Street estimate.
The platform enables the assessment of hemoglobin levels at the point of care and quantitatively measures hemoglobin in capillary or venous whole blood.
The infusion set is designed to work with the company's Kurin Lock system for the prevention of blood collection contamination and false positives.
The Erytra Eflexis is a fully automated benchtop analyzer for pretransfusion compatibility testing that facilitates multiple lab configurations and features real random access.
Sysmex accuses 13 Beckman Coulter instruments of infringing 11 claims in the patent, which covers a system analyzer and a computer program.
The company also said that it received ISO 13485:2016 certification for its Mosaiq platform and it has filed for CE marking for its initial immunohematology microarray.
The miniature analyzer, which uses disposable cartridges that include all necessary reagents, is designed to provide results from one drop of blood.
The recall affects certain lot numbers and package sizes that were manufactured and distributed between January 12 and October 29 of this year and involves more than 1.1 million packages.
The instrument is a centrifuge/reader combo that automatically reads and transfers blood type and antibody screening results to patient data management software.
The ID Core XT is the second molecular assay approved by the FDA for use in transfusion medicine and the first to report genotypes as final results.
Its platform is being developed for several medical conditions using separate modules to measure cells, proteins, nucleic acids, enzymes, and small molecules.
In May, Kurin sued Magnolia for allegedly making false claims about the efficacy and regulatory status of its Steripath blood culture collection system.
The battery-operated, hand-held device uses a broad-spectrum photometric method to provide accurate hemoglobin measurements in about one second.
The company's Life Sciences segment was up 17 percent year over year, while its Diagnostics business grew 8 percent.
The assay is designed to quickly determine if a patient may be developing thrombocytopenia while being treated with the blood thinner heparin.